Important Opportunity for Agenus Inc. Shareholders
The Gross Law Firm is reaching out to shareholders affected by Agenus Inc. (NASDAQ: AGEN) with an important announcement. They invite shareholders who acquired AGEN stock during the designated period to explore their legal rights and the potential advantages of joining a class action lawsuit.
Details About the Class Period
This class action covers the period from January 23, 2023, to July 17, 2024. Within this timeframe, investors may have encountered misleading information regarding the effectiveness of the company's products. This legal action aims to assist those who relied on AGEN's statements and sustained losses as a result.
Why It's Important to Act Quickly
It's vital for investors to take swift action. The last day to register for participation in this class action is November 5, 2024. Early registration is strongly recommended to ensure that your voice is heard and that you can potentially lead the efforts.
Overview of Allegations Against Agenus Inc.
The claims against AGEN focus on allegations that the company disseminated materially false or misleading statements regarding the effectiveness of their immuno-oncology products. Specifically, the combination therapy of botensilimab and balstilimab was reportedly less effective than claimed. As a result, the company's public disclosures are viewed as misleading, posing significant risks for investors.
How to Join the Class Action
If you bought shares of AGEN during the applicable class action period, you're encouraged to register with the Gross Law Firm. By enrolling, you'll receive updates and gain access to monitoring tools that will track the case's progress. Joining the class action comes with no fees or obligations — your existing investments and rights are the top priority.
The Gross Law Firm's Commitment
The Gross Law Firm is recognized as a leading class action law firm focused on defending investor rights. Their mission is to hold corporations accountable for misleading investors and to uphold corporate governance. Utilizing their expertise, they handle the complexities of the financial world to ensure justice for affected shareholders.
Dedication to Investors
This dedication reflects the firm’s resolve to advocate for investors impacted by corporate misconduct. They prioritize ethical business practices and transparency in the financial market.
How to Get in Touch
If you're looking to connect or want to learn more about participating in the class action, you can find The Gross Law Firm's contact details below:
The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY 10018
Email: dg@securitiesclasslaw.com
Phone: (646) 453-8903
Frequently Asked Questions
What’s the last day to join the class action against Agenus Inc.?
The last day to register is November 5, 2024.
Who is eligible to participate in this class action?
Shareholders who purchased stock in Agenus Inc. between January 23, 2023, and July 17, 2024, can join.
What are the main allegations against Agenus Inc.?
The allegations center around misleading statements regarding the effectiveness of their drug therapies, which have affected investors' decisions.
Are there any fees to join the class action?
No, joining this lawsuit comes with no costs or obligations.
How can I reach The Gross Law Firm for more information?
You can email them at dg@securitiesclasslaw.com or call them at (646) 453-8903.